A carregar...
The predictive value of early molecular response in chronic myeloid leukaemia patients treated with imatinib in a single real-world medical centre in a developing country
INTRODUCTION: The prognosis of patients with chronic myeloid leukaemia (CML) has improved since the introduction of imatinib. However, patients who do not achieve complete cytogenetic response (CCyR) and major molecular response (MMR) have poorer prognosis. Recent clinical trials have demonstrated t...
Na minha lista:
| Publicado no: | Singapore Med J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Singapore Medical Association
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5360871/ https://ncbi.nlm.nih.gov/pubmed/27029807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11622/smedj.2016063 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|